Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

Also called NCT04952051

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04952051
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04952051. Randomized; no masking; primary purpose treatment. Start 2014-07-01 (actual); primary completion 2019-07-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
Condition
Hypertension
Intervention (Drug)
Enalapril Folic Acid Tablets Combined With amlodipine
Intervention (Drug)
Enalapril Folic Acid Tablets Combined With hydrochlorothiazide
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
National Clinical Research Center, Southern Medical University (class: not stated)
Collaborator
Ningbo Yinzhou Community Health Service Center (class: not stated)

Record details

Record id
cardio:ct-nct04952051
Content hash
7f94a7de706d9dfe0f376e931c768f42ae4a7f12a521f7e88d1673026ebd3b0a